Hello Everyone and Good Morning. We have been waiting for news to drop about Healight for a while, but they have been telling us everything we need to know all along. Follow the trail I put together below. They have announced the preclinical results. They have been talking to the FDA. They have the pilot catheters. They are using them on humans. They are working on humans. It is all there. We just have to piece the stories together.
Dr. Rezaie
Over the last four years after thousands of experiments and >1000 mouse colonoscopies, we have decoded the wavelength, peaks & the dose of ultraviolet-A light needed to safely kill multiple bacteria & fungi!
NJ Biz May 1st 2020.
Upon completion of the catheter, the Healight will move into pilot-scale manufacturing of the device that will be used by Cedars-Sinai for testing in a clinical setting.
Cedars-Sinai, Aytu BioScience and Sterling Medical Devices are working with the FDA to determine an expedited regulatory process to potentially enable near-term human use of coronavirus intervention for critically ill intubated patients.
From corporate presentation.
Development and commercialization of licensed Healight technology platform
PreclinicaldevelopmentconductedatCedars-Sinai
COVID-19emergencyusependingoutcomeofdiscussionswithFDA
– ClinicalapplicationsbeyondCOVID-19 • Ventilator-associated pneumonia (VAP)
• Influenza
• Severe infections of hospitalized patients
From L.A. Daily News May 27th.
"We attribute these results to our extensive experience treating complex cases, meticulous care in our ICUs, the use of new and experimental therapies and a manageable volume of COVID-19 patients," said Richard V. Riggs, MD, senior vice president of Medical Affairs and chief medical officer.
Market Data 
Markets 
AI
